Connect with us

Hi, what are you looking for?

Jewish Business News

World News

Flight Cancellations May Jeopardize Israeli Nasdaq IPOs

Investors are already asking questions and taking an interest in the possibility of a postponement until the situation is clarified.

Nasdaq israel

Six Israeli biomed companies which were about to go public on Nasdaq are still conducting meetings with investors, and, according to a Globes report, are not seeing any attention being paid directly to the security events in Israel, and none of their meeting with investors have been canceled. It appears, however, that the seriousness of the situation is being gradually realized in the US.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.

Managers and parties involved with the IPOs with whom “Globes” spoke yesterday reported today that the situation has changed following the cancellation of flights to and from Israel announced yesterday by foreign airlines. It appears that this declaration has overcome US inhibitions, and the investors are already asking questions and taking an interest in the possibility of a postponement until the situation is clarified.

“They’re asking, ‘How will the situation affect your company, ‘ and you have to decide how to address it, ” a manager told “Globes.” “In contrast to the missiles being intercepted in the sky without ever reaching the ground, the halt in flights can also affect a company with no operations in Israel other than an office. It also highlights to potential investors that this round of fighting is different than the previous ones, and that the concept of ‘It passes, Israelis always recover, and things go back to the way they were before within a short time’ is now considered questionable.”

The companies scheduled to hold Nasdaq IPOs soon are Mapi-Pharma (improved generic drugs), Silenseed (a drug for pancreatic cancer), Macro Cure (wound healing), VBL Therapeutics (drugs for cancer and infectious diseases), ReWalk Robotics (a walking device for paralytics), and BioBlast Pharma (drugs for rare diseases). The companies intend to raise an aggregate $319 million. Even before the outbreak of war in the Gaza Strip, it was not certain whether the companies would succeed in completing their offerings at the planned values.

At the same time, it is possible that the situation in the US and the general appetite for biomed offerings will have a greater effect on the IPOs’ success than the situation in Israel. The Nasdaq biotech index has been rising in recent days, with a 3% return since the beginning of the week.

Published by Globes [online], Israel business news – – on July 23, 2014



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.